The occurrence of MYCN amplification in approximately 20% of neuroblastomas, which correlates with high-risk disease and poor prognosis (11), further underscores the importance of MYC and HIF signaling pathways in these adrenal neoplasms derived from the neural crest. This evidence concerns the gene MYCN and neuroblastoma.